Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

(-)-Huperzine A

Acetylcholine esterase inhibitor
 
ALX-550-065-MC05 0.5 mg 41.00 USD
 
ALX-550-065-M001 1 mg 73.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: BML-C117

Plant alkaloid. Neurotoxin. Potent acetylcholinesterase inhibitor. Active isomer with acetylcholine esterase activity. Protects cells against hydrogen peroxide, β-amyloid, glutamate, ischemia and staurosporine-induced cytotoxicity and apoptosis. Prospective agent for the treatment of Alzheimer's disease. For the racemic modification, see (±)-Huperzine A (Prod. No. ALX-550-064).

Product Specification

Alternative Name:(-)-Selagine
 
Formula:C15H18N2O
 
MW:242.3
 
Source:Isolated from Lycopodium sp.
 
CAS:102518-79-6
 
MI:14: 4755
 
RTECS:PB9185700
 
Purity:≥95%
 
Appearance:White to off-white solid.
 
Solubility:Soluble in methanol or DMSO.
 
Shipping:Ambient
 
Long Term Storage:+4°C
 
ALX-550-065
Please mouse over
ALX-550-065

Product Literature References

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine: R. Wang, et al.; Acta Pharmacol. Sin. 27, 1 (2006), (Review), Abstract;
Huperzine A, a potential therapeutic agent for treatment of Alzheimer’s disease: D.L. Bai, et al.; Curr. Med. Chem. 7, 355 (2000), (Review), Abstract;
Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate: H.S. Ved, et al.; Neuroreport 8, 963 (1997), Abstract;
An Improved Synthetic Route to Huperzine A; New Analogues and Their Inhibition of Acetylcholinesterase: A.P. Kozikowski, et al.; J. C. S. Chem. Commun. 860 (1993),
Natural and synthetic Huperzine A: effect on cholinergic function in vitro and in vivo: I. Hanin, et al.; Ann. N. Y. Acad. Sci. 695, 304 (1993), Abstract;
Mechanism of inhibition of cholinesterases by huperzine A: Y. Ashani; BBRC 184, 719 (1992), Abstract;
Potencies and stereoselectivities of enantiomers of huperzine A for inhibition of rat cortical acetylcholinesterase: M. McKinney, et al.; Eur. J. Pharmacol. 203, 303 (1991), Abstract;
Synthesis and Biological Evaluation of (±)-Z-Huperzine A: A.P. Kozikowski, et al.; Tetrahedron Lett. 31, 6159 (1990),
A Practical Synthesis of the Chinese "Nootropic" Agent Huperzine A: A Possible Lead in the Treatment of Alzheimer's Disease: Y. Xia & A.P. Kozikowski; JACS 111, 4116 (1989),
Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat: X.C. Tang, et al.; J. Neurosci. Res. 24, 276 (1989), Abstract;
Cholinesterase inhibition by huperzine B: H. Xu & X.C. Tang; Zhongguo Yao Li Xue Bao 8, 18 (1987), Abstract;
Effects of huperzine A on learning and the retrieval process of discrimination performance in rats: X.C. Tang, et al.; Zhongguo Yao Li Xue Bao 7, 507 (1986), Abstract;
The effect of the nucleoside transport inhibitor dipyridamole on the incorporation of [3H]thymidine in the rat: J.-S. Liu, et al.; Can. J. Chem. 64, 837 (1986),

Related Products

(±)-Huperzine A 

Acetylcholine esterase inhibitor
120786-18-7, Synthetic., ≥95% | Print as PDF
 
ALX-550-064-M001 1 mg 55.00 USD
 
ALX-550-064-M005 5 mg 186.00 USD
Do you need bulk/larger quantities?
 

Related Literature

Brochures
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

Technical Posters
Disease-Associated Stress Signaling
Disease-Associated Stress Signaling
Download as PDF

All new literature pieces

Recommend this page

 
Keep in touch

©2017 Enzo Life Sciences, Inc.,